Lung Function and Mortality in the United States: Data from the First National Health and Nutrition Examination Survey Follow Up Study

Overview

Journal Thorax

Date 2003 May 3

PMID 12728157

Citations 231

Authors

D M Mannino

A S Buist

T L Petty

P L Enright

S C Redd

Affiliations

Soon will be listed here.

Abstract

Background: A study was undertaken to define the risk of death among a national cohort of US adults both with and without lung disease.

Methods: Participants in the first National Health and Nutrition Examination Survey (NHANES I) followed for up to 22 years were studied. Subjects were classified using a modification of the Global Initiative for Chronic Obstructive Lung Disease criteria for chronic obstructive pulmonary disease (COPD) into the following mutually exclusive categories using the forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), FEV(1)/FVC ratio, and the presence of respiratory symptoms: severe COPD, moderate COPD, mild COPD, respiratory symptoms only, restrictive lung disease, and no lung disease. Proportional hazard models were developed that controlled for age, race, sex, education, smoking status, pack years of smoking, years since quitting smoking, and body mass index.

Results: A total of 1301 deaths occurred in the 5542 adults in the cohort. In the adjusted proportional hazards model the presence of severe or moderate COPD was associated with a higher risk of death (hazard ratios (HR) 2.7 and 1.6, 95% confidence intervals (CI) 2.1 to 3.5 and 1.4 to 2.0), as was restrictive lung disease (HR 1.7, 95% CI 1.4 to 2.0).

Conclusions: The presence of both obstructive and restrictive lung disease is a significant predictor of earlier death in long term follow up.

Citing Articles

Baseline total lung capacity and all-cause mortality in restrictive pulmonary disorders: a meta-analysis.

Li F, Chen Y, Zhang G, Liu M, Zeng H, Dai H BMC Pulm Med. 2025; 25(1):103.

PMID: 40055715 PMC: 11889751. DOI: 10.1186/s12890-024-03425-8.

Prevalence of pulmonary dysfunction and its risk factors in patients with transfusion-dependent thalassaemia: protocol for a systematic review and meta-analysis.

Liang X, Lu Y, Huang Y, Pan L, Wu M, Lai Y BMJ Open. 2025; 15(2):e091847.

PMID: 39965944 PMC: 11836804. DOI: 10.1136/bmjopen-2024-091847.

Risk of All-Cause Mortality in US Adults With Preserved Ratio Impaired Spirometry: An Observational Study.

Xiao S, Ou J, Qiu W, Ye C, Li N, Chen S Int J Chron Obstruct Pulmon Dis. 2025; 20:287-302.

PMID: 39959844 PMC: 11829583. DOI: 10.2147/COPD.S497674.

Risk of All-Cause Mortality in Mild Chronic Obstructive Pulmonary Disease: Evidence From the NHANES III and 2007-2012.

Zou W, Ou J, Wu F, Xiao S, Deng Z, Li H Int J Chron Obstruct Pulmon Dis. 2025; 20:217-229.

PMID: 39901929 PMC: 11789505. DOI: 10.2147/COPD.S497634.

Metabolic Health, Overweight or Obesity, and Lung Function in Older Australian Adults.

Opio J, Wynne K, Attia J, Hancock S, McEvoy M Nutrients. 2025; 16(24.

PMID: 39770878 PMC: 11676256. DOI: 10.3390/nu16244256.

References

Knuiman M, James A, Divitini M, Ryan G, Bartholomew H, Musk A . Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol. 2000; 9(5):297-306. DOI: 10.1016/s1047-2797(98)00066-0. View

Cox C, Mussolino M, Rothwell S, Lane M, Golden C, Madans J . Plan and operation of the NHANES I Epidemiologic Followup Study, 1992. Vital Health Stat 1. 1998; (35):1-231. View

Aaron S, Dales R, Cardinal P . How accurate is spirometry at predicting restrictive pulmonary impairment?. Chest. 1999; 115(3):869-73. DOI: 10.1378/chest.115.3.869. View

Ryan G, Knuiman M, Divitini M, James A, Musk A, Bartholomew H . Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health. 1999; 53(4):230-4. PMC: 1756854. DOI: 10.1136/jech.53.4.230. View

Neas L, Schwartz J . Pulmonary function levels as predictors of mortality in a national sample of US adults. Am J Epidemiol. 1998; 147(11):1011-8. DOI: 10.1093/oxfordjournals.aje.a009394. View

Sharp D, Masaki K, Burchfiel C, Yano K, SCHATZ I . Prolonged QTc interval, impaired pulmonary function, and a very lean body mass jointly predict all-cause mortality in elderly men. Ann Epidemiol. 1998; 8(2):99-106. DOI: 10.1016/s1047-2797(97)00121-x. View

Ferguson G, Enright P, Buist A, Higgins M . Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest. 2000; 117(4):1146-61. DOI: 10.1378/chest.117.4.1146. View

Mannino D, Gagnon R, Petty T, Lydick E . Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160(11):1683-9. DOI: 10.1001/archinte.160.11.1683. View

Pelkonen M, Tukiainen H, Tervahauta M, Notkola I, Kivela S, Salorinne Y . Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax. 2000; 55(9):746-50. PMC: 1745841. DOI: 10.1136/thorax.55.9.746. View

10.

Schunemann H, Dorn J, Grant B, Winkelstein Jr W, Trevisan M . Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000; 118(3):656-64. DOI: 10.1378/chest.118.3.656. View

11.

Engstrom G, Hedblad B, Janzon L, Valind S . Respiratory decline in smokers and ex-smokers--an independent risk factor for cardiovascular disease and death. J Cardiovasc Risk. 2000; 7(4):267-72. DOI: 10.1177/204748730000700404. View

12.

Hospers J, Postma D, Rijcken B, Weiss S, Schouten J . Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000; 356(9238):1313-7. DOI: 10.1016/S0140-6736(00)02815-4. View

13.

Maltais F, Leblanc P, Jobin J, Casaburi R . Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med. 2001; 21(4):665-77. DOI: 10.1016/s0272-5231(05)70176-3. View

14.

Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

15.

OBrien R, Drizd T . Basic data on spirometry in adults 25-74 years of age: United States, 1971-75. Vital Health Stat 11. 1981; (222):1-36. View

16.

Cohen B, Barbano H, Cox C, Feldman J, Finucane F, Kleinman J . Plan and operation of the NHANES I Epidemiologic Followup Study: 1982-84. Vital Health Stat 1. 1987; (22):1-142. View

17.

Burrows B, Bloom J, Traver G, Cline M . The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987; 317(21):1309-14. DOI: 10.1056/NEJM198711193172103. View

18.

Postma D, SLUITER H . Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis. 1989; 140(3 Pt 2):S100-5. DOI: 10.1164/ajrccm/140.3_Pt_2.S100. View

19.

Anthonisen N . Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis. 1989; 140(3 Pt 2):S95-9. DOI: 10.1164/ajrccm/140.3_Pt_2.S95. View

20.

Finucane F, Freid V, Madans J, Cox C, Kleinman J, Rothwell S . Plan and operation of the NHANES I Epidemiologic Followup Study, 1986. Vital Health Stat 1. 1990; (25):1-154. View